Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT01106313
The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Observational
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1)Willingness to sign the Human Subject Protection Consent Form prior to enrollment into the study.
2)Men and women ages 20 to 65 years of age. 3)Diagnosis of unipolar, non-psychotic, non-melancholic major depressive disorder (MDD) or depressive episode of bipolar disorder (Bipolar I, II or NOS), based on a Structured Clinical Interview for DSM-IV Axis I disorders (SCID) and confirmed by a psychiatrist.
5)Adequate visual and auditory acuity to allow neuropsychological testing. 6)Stable regime of psychiatric medications for 1 month prior to insulin test. Exclusion Criteria:1)Diagnosis of possible or probable cognitive impairment.
2)For women only: pregnancy, breastfeeding. 3)Personal history of Type I or Type II diabetes. 4) Unstable cardiovascular disease or other major medical condition, or history of myocardial infarction within the previous year.
5)Significant cerebrovascular disease, as evidenced by neurological examination, uncontrolled hypertension (systolic blood pressure > 170 or diastolic blood pressures > 100).
Time frame: Within 3 hours of initial infusion
Time frame: 1 wk
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02664467
Behavior, Behavioral Symptoms
Lugano, Canton Ticino, Switzerland
View Trial DetailsNCT01360866
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT02196506
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT01727726
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial Details